Aditum Bio Partners with Westwood & Wilshire to Fill Vice President - Business Development and Licensing
Dr. Ilan Zipkin has joined Aditum Bio as the new Vice President of Business Development and Licensing. Dr. Zipkin has joined from Parker Institute for Cancer Immunotherapy where he served in a similar capacity as Vice President of Business Development. He has worked for organizations such as Takeda, MPM Capital, BioCentury Publications, etc. Dr. Zipkin has obtained his Ph.D. in Cell Biology and Biochemistry from UC San Francisco.
This search was successfully led by Michael Cane.
At Westwood & Wilshire, we recognize that people are an organization's top asset. We are passionate about delivering premier talent to the world’s most innovative companies. We are particularly focused on companies ranging from VC-backed start-ups to mid-sized commercial entities and our assignments range from C-Suite to mid-management. Our firm has offices in Los Angeles, Silicon Valley, and Seattle, serving clients on a local, national and global basis.